The high-level meeting of Wanbangde Pharmaceutical Group was held in the beautiful Yandang Mountain from December 24th to 25th. The meeting adhered to the guiding idea that the overall strategy should be stable, the target positioning should be accurate, the enterprise management should be active, the work measures should be practical, and the thinking and understanding should be unified. The 2017 annual work goals and plans will be discussed and studied in a comprehensive and detailed manner, and the work of each department in the coming year will be deployed in a targeted manner. The meeting was presided over by Vice President of Administration Chen Yan, and Chairman Zhao Shouming made an important speech. The principals of various departments of the company attended the meeting.

At the meeting, Chairman Zhao Shouming pointed out that Wanbangde Pharmaceutical Group is about to usher in 2017 at the node of industrial structure adjustment and improvement, and integration speed up. Click to start, comprehensively promote the reform and development of enterprises. He pointed out that in 2016, the company's development was in a period of adjustment, the overall operation of the company was improving, the management level was significantly improved, the industrial structure adjustment had made significant progress, and the main goals and tasks for the year had been basically completed. He especially emphasized that this year, the company has made bold innovations on the basis of the existing management system and has made great progress, especially in the formation of technical research and development teams, new breakthroughs in the research of key product - Huperzine A, ginkgo biloba The secondary development of Yediwan, the construction of distribution and marketing system, the improvement of production cost accounting system, the continuous deepening of corporate culture construction, and the solid promotion of informatization work are outstanding.

He said that while affirming the achievements in 2016, he must also clearly recognize that there are still many problems in the development of the company. Since the beginning of this year, the business development of various sectors of the enterprise has shown a spiral upward trend. However, the construction of the talent echelon cannot meet the needs of enterprise development, and the lack of middle management personnel and faults restrict the development of the enterprise. In addition, in the process of rapid business growth, there is a lack of effective communication and collaboration among various departments, resulting in a lag in work. The execution and ideological awareness of the overall team of the enterprise need to be improved urgently, and a good communication and collaboration mechanism needs to be established. At the same time, the phenomenon of raw material waste still occurs from time to time, and the awareness of cost budgeting and control needs to be improved urgently. It is necessary to further improve the cost supervision and control mechanism to effectively reduce costs. The market share of individual products is still relatively low. It is necessary to innovate the marketing model in a timely manner, strengthen the marketing network, expand the product sales channels, and help the development of the enterprise to a new level.

At the end of the meeting, it was emphasized that in 2017, the company must firmly grasp the main line of enterprise development of adjusting structure, maintaining quality, laying foundation, strengthening talents, grasping management, and promoting brand, further unifying thinking and understanding, and enhancing communication and cooperation between departments. Concentrate and work hard to ensure the continuous release of production capacity and the continuous growth of interests, and continue to strive to create a better tomorrow for Wanbangde Pharmaceutical Group.

Group photo of senior executives of Wanbangde Pharmaceutical Group